BRD4 directs hematopoietic stem cell development and modulates macrophage inflammatory responses
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
BRD4 is a BET family protein that binds acetylated histones and regulates transcription. BET/BRD4 inhibitors block blood cancer growth and inflammation and serve as a new therapeutic strategy. However, the biological role of BRD4 in normal hematopoiesis and inflammation is not fully understood. Analysis of Brd4 conditional knockout (KO) mice showed that BRD4 is required for hematopoietic stem cell expansion and progenitor development. Nevertheless, BRD4 played limited roles in macrophage development and inflammatory response to LPS ChIP-seq analysis showed that despite its limited importance, BRD4 broadly occupied the macrophage genome and participated in super-enhancer (SE) formation. Although BRD4 is critical for SE formation in cancer, BRD4 was not required for macrophage SEs, as KO macrophages created alternate, BRD4-less SEs that compensated BRD4 loss. This and additional mechanisms led to the retention of inflammatory responses in macrophages. Our results illustrate a context-dependent role of BRD4 and plasticity of epigenetic regulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
Chen, E. Y., Tan, C. M., Kou, Y., Duan, Q., Wang, Z., Meirelles, G. V., Clark, N. R., & Ma’ayan, A. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-128 · Cited by 7,814 · cited 1×
“GO analysis was performed using the Enrichr program (Chen et al , 2013).”
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262 · cited 1×
“…related diseases, including LPS-induced sepsis, EAE-based neuroinflammation, diabetes, and cardio-vascular diseases (Nicodeme et al , 2010; Bandukwala et al , 2012; Anand et al , 2013; Belkina et al , 2013; Mele et al , 2013; Brown Jonathan et al , 2014; Fu et al , 2014; Duan et al , 2017).”
Super-enhancers in the control of cell identity and disease
Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-André, V., Sigova, A. A., Hoke, H. A., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.09.053 · Cited by 3,662 · cited 5×
“SEs are large regulatory DNAs, enriched with RNA polymerase II (PoI II) and acetylated H3 at K27 (H3K27ac) (Hnisz et al , 2013).”
InfluentialSelective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Lovén, J., Hoke, H. A., Lin, C. Y., Lau, A., Orlando, D. A., Vakoc, C. R., Bradner, J. E., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.036 · Cited by 2,961 · cited 6×
“Thus, BRD4 may regulate multiple cell cycle genes in these cells, although it has been proposed that BRD4 drives cancer growth by enhancing c-Myc (Zuber et al , 2011; Love´n et al , 2013; Pelish et al , 2015).”
InfluentialRNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Zuber, J., Shi, J., Wang, E., Rappaport, A. R., Herrmann, H., Sison, E. A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M., et al. (2011) · Nature · doi:10.1038/nature10334 · Cited by 1,870 · cited 2×
“Thus, BRD4 may regulate multiple cell cycle genes in these cells, although it has been proposed that BRD4 drives cancer growth by enhancing c-Myc (Zuber et al , 2011; Love´n et al , 2013; Pelish et al , 2015).”
Suppression of inflammation by a synthetic histone mimic
Nicodeme, E., Jeffrey, K. L., Schaefer, U., Beinke, S., Dewell, S., Chung, C.-W., Chandwani, R., Marazzi, I., Wilson, P., Coste, H., et al. (2010) · Nature · doi:10.1038/nature09589 · Cited by 1,563 · cited 1×
“BRD4 broadly occupies various regions of the genome by binding to acetylated histones (Dey et al , 2003, 2009; Nishiyama et al , 2006; Zhang et al , 2012; Hnisz et al , 2013; Love´n et al , 2013; Kanno et al , 2014).”
An Abundance of Ubiquitously Expressed Genes Revealed by Tissue Transcriptome Sequence Data
Ramsköld, D., Wang, E. T., Burge, C. B., & Sandberg, R. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000598 · Cited by 820
Two physically, functionally, and developmentally distinct peritoneal macrophage subsets
Ghosn, E. E. B., Cassado, A. A., Govoni, G. R., Fukuhara, T., Yang, Y., Monack, D. M., Bortoluci, K. R., Almeida, S. R., Herzenberg, L. A., & Herzenberg, L. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915000107 · Cited by 689
NF-κB Directs Dynamic Super Enhancer Formation in Inflammation and Atherogenesis
Brown, J. D., Lin, C. Y., Duan, Q., Griffin, G., Federation, A. J., Paranal, R. M., Bair, S., Newton, G., Lichtman, A. H., Kung, A. L., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.024 · Cited by 614 · cited 1×
“…related diseases, including LPS-induced sepsis, EAE-based neuroinflammation, diabetes, and cardio-vascular diseases (Nicodeme et al , 2010; Bandukwala et al , 2012; Anand et al , 2013; Belkina et al , 2013; Mele et al , 2013; Brown Jonathan et al , 2014; Fu et al , 2014; Duan et al , 2017).”
Convergence of Developmental and Oncogenic Signaling Pathways at Transcriptional Super-Enhancers
Hnisz, D., Schuijers, J., Lin, C. Y., Weintraub, A. S., Abraham, B. J., Lee, T. I., Bradner, J. E., & Young, R. A. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.02.014 · Cited by 476 · cited 1×
“While most enhancers are so-called typical enhancers (TEs), super-enhancers (SEs) are longer in length, encompassing more than 12 Kb, enriched with transcription factors, Pol II, chromatin modifiers, etc. (Hnisz et al , 2015, 2017).”
Cited by
Achieving clinical success with BET inhibitors as anti-cancer agents
Shorstova, T., Foulkes, W. D., & Witcher, M. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01321-0 · Cited by 347
Super enhancer regulation of cytokine-induced chemokine production in alcoholic hepatitis
Liu, M., Cao, S., He, L., Gao, J., Arab, J. P., Cui, H., Xuan, W., Gao, Y., Sehrawat, T. S., Hamdan, F. H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24843-w · Cited by 120
Feng, L., Wang, G., Chen, Y., He, G., Liu, B., Liu, J., Chiang, C., & Ouyang, L. (2022) · Medicinal Research Reviews · doi:10.1002/med.21859 · Cited by 65
Saeki, K., Pan, R., Lee, E., Kurotaki, D., & Ozato, K. (2024) · Nature Immunology · doi:10.1038/s41590-024-01962-2 · Cited by 55
“As the H3K27ac is a surrogate marker for superenhancers and superenhancers are neighbors for many genes critical for defining cell-type specificity and function 35,36 , we examined superenhancers using the ROSE program 35 .”
Self-citationVeerasubramanian, P. K., Shao, H., Meli, V. S., Phan, T. A. Q., Luu, T. U., Liu, W. F., & Downing, T. L. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121236 · Cited by 28
“Well-known members of the BET family of proteins include BRD2 and BRD4, both of which have been implicated in inflammation based on their localization to inflammatory gene promoters during macrophage polarization [19,20].”
Background
Metadata
- Authors
- Dey, A., Yang, W., Gegonne, A., Nishiyama, A., Pan, R., Yagi, R., Grinberg, A., Finkelman, F. D., Pfeifer, K., Zhu, J., Singer, D., Zhu, J., & Ozato, K.
- Venue
- The EMBO Journal
- Published
- 2019-03-06
- Volume
- 38
- Issue
- 7
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W2920620505
- Cited by
- 125
- References
- 14
- FWCI
- 5.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: BRD4 directs hematopoietic stem cell development and modulates macrophage inflammatory responses. https://app.cochat.ai/papers/10.15252/embj.2018100293
- The paper
- Dey, A., Yang, W., Gegonne, A., Nishiyama, A., Pan, R., Yagi, R., Grinberg, A., Finkelman, F. D., Pfeifer, K., Zhu, J., Singer, D., Zhu, J., & Ozato, K. (2019). BRD4 directs hematopoietic stem cell development and modulates macrophage inflammatory responses. The EMBO Journal. https://doi.org/10.15252/embj.2018100293
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.